论文部分内容阅读
目的探讨脾氨肽对于巨细胞病毒感染儿童细胞免疫功能的影响及治疗作用。方法将74例巨细胞病毒感染患儿分为试验组37例和对照组37例。对照组予以保护脏器等对症的基础治疗,试验组除同等的基础治疗外予以口服脾氨肽冻干粉口服。结果两组患儿治疗后的CD4~+和CD4~+/CD8~+均较前上升(P<0.05),且试验组上升更明显(P<0.05),而两组的CD8~+下降均十分显著(P<0.01),但下降程度上没有差异(P>0.05)。试验组的临床总有效率为94.59%,要高于对照组;两组在治疗后的全血CMV-DNA载量均明显下降(P均<0.05),且试验组的下降要更为显著(P<0.05)。结论脾氨肽能纠正儿童巨细胞病毒感染时的T淋巴细胞亚群失衡,改善细胞免疫功能,有一定的治疗效果。
Objective To investigate the effect and therapeutic effect of spleen ammonia peptide on cellular immune function in children with cytomegalovirus infection. Methods 74 cases of cytomegalovirus infection were divided into experimental group 37 cases and control group 37 cases. The control group to protect the symptomatic treatment of organ and other basic treatment, the experimental group in addition to the same basic treatment to oral spleen ammonia peptide lyophilized powder oral administration. Results The CD4 ~ + and CD4 ~ + / CD8 ~ + levels in both groups were significantly higher than those in the control group (P <0.05) (P <0.01), but there was no difference between the two groups (P> 0.05). The total clinical effective rate of the experimental group was 94.59%, which was higher than that of the control group. The CMV-DNA load of the whole blood of the two groups were significantly decreased (all P <0.05), and the decline of the experimental group was more significant P <0.05). Conclusion Spleen ammonia peptide can correct the imbalance of T lymphocyte subsets in childhood cytomegalovirus infection and improve the cellular immune function, and has a certain therapeutic effect.